OcuCure Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2005-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.ocucure.com
Clinical Trials
2
Active:0
Completed:1
Trial Phases
2 Phases
Phase 1:1
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 2
1 (50.0%)A Study Assessing Efficacy and Safety of OC-10X in the Treatment of PDR
Phase 2
Terminated
- Conditions
- Proliferative Diabetic Retinopathy (PDR)
- Interventions
- Drug: Placebo ComparatorDrug: 2% OC-10X
- First Posted Date
- 2016-04-12
- Last Posted Date
- 2017-04-05
- Lead Sponsor
- OcuCure Therapeutics, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT02735369
- Locations
- 🇧🇩
Bangladesh Eye Hospital, Dhaka, Bangladesh
Phase I Study Assessing the Ocular and Systemic Safety and Tolerability of OC-10X
- First Posted Date
- 2013-06-05
- Last Posted Date
- 2016-01-22
- Lead Sponsor
- OcuCure Therapeutics, Inc.
- Target Recruit Count
- 10
- Registration Number
- NCT01869933
- Locations
- 🇧🇩
Bangladesh Eye Hospital, Dhaka, Bangladesh
News
No news found